Articles with public access mandates - claudio cuelloLearn more
Not available anywhere: 23
Intracellular Aβ-oligomers and early inflammation in a model of Alzheimer's disease
MT Ferretti, MA Bruno, A Ducatenzeiler, WL Klein, AC Cuello
Neurobiology of aging 33 (7), 1329-1342, 2012
Mandates: US National Institutes of Health, Canadian Institutes of Health Research
Neuronal driven pre-plaque inflammation in a transgenic rat model of Alzheimer's disease
CE Hanzel, A Pichet-Binette, LSB Pimentel, MF Iulita, S Allard, ...
Neurobiology of aging 35 (10), 2249-2262, 2014
Mandates: Canadian Institutes of Health Research
ADAM-10 over-expression increases cortical synaptogenesis
KFS Bell, L Zheng, F Fahrenholz, AC Cuello
Neurobiology of aging 29 (4), 554-565, 2008
Mandates: Canadian Institutes of Health Research, German Research Foundation
Nerve growth factor metabolic dysfunction in Alzheimer's disease and Down syndrome
MF Iulita, AC Cuello
Trends in pharmacological sciences 35 (7), 338-348, 2014
Mandates: Canadian Institutes of Health Research
Early and late CNS inflammation in Alzheimer’s disease: two extremes of a continuum?
AC Cuello
Trends in pharmacological sciences 38 (11), 956-966, 2017
Mandates: Canadian Institutes of Health Research
Connecting the “dots”: from free radical lipid autoxidation to cell pathology and disease
MK Foret, R Lincoln, S Do Carmo, AC Cuello, G Cosa
Chemical Reviews 120 (23), 12757-12787, 2020
Mandates: Canadian Institutes of Health Research, Natural Sciences and Engineering …
Reimagining cholinergic therapy for Alzheimer’s disease
E Giacobini, AC Cuello, A Fisher
Brain 145 (7), 2250-2275, 2022
Mandates: US National Institutes of Health, Canadian Institutes of Health Research
Evidence of intraneuronal Aβ accumulation preceding tau pathology in the entorhinal cortex
LA Welikovitch, S Do Carmo, Z Maglóczky, P Szocsics, J Lőke, T Freund, ...
Acta neuropathologica 136, 901-917, 2018
Mandates: Canadian Institutes of Health Research, Fonds de recherche du Québec - Santé
NLRP3-dependent synaptic plasticity deficit in an Alzheimer's disease amyloidosis model in vivo
Y Qi, I Klyubin, AC Cuello, MJ Rowan
Neurobiology of Disease 114, 24-30, 2018
Mandates: Health Research Board, Ireland, Science Foundation Ireland
Analysis of matrix metallo-proteases and the plasminogen system in mild cognitive impairment and Alzheimer's disease cerebrospinal fluid
CE Hanzel, MF Iulita, H Eyjolfsdottir, E Hjorth, M Schultzberg, ...
Journal of Alzheimer's disease 40 (3), 667-678, 2014
Mandates: Canadian Institutes of Health Research, Swedish Research Council
AF710B, an M1/sigma-1 receptor agonist with long-lasting disease-modifying properties in a transgenic rat model of Alzheimer's disease
H Hall, MF Iulita, P Gubert, LF Aguilar, A Ducatenzeiler, A Fisher, ...
Alzheimer's & Dementia 14 (6), 811-823, 2018
Mandates: Canadian Institutes of Health Research, Fonds de recherche du Québec - Santé
Identification and preliminary validation of a plasma profile associated with cognitive decline in dementia and at-risk individuals: a retrospective cohort analysis
MF Iulita, A Ganesh, R Pentz, L Flores Aguilar, P Gubert, A Ducatenzeiler, ...
Journal of Alzheimer's Disease 67 (1), 327-341, 2019
Mandates: Canadian Institutes of Health Research, National Institute for Health …
Compromise of cortical proNGF maturation causes selective retrograde atrophy in cholinergic nucleus basalis neurons
S Allard, ML Jacobs, S Do Carmo, AC Cuello
Neurobiology of aging 67, 10-20, 2018
Mandates: Canadian Institutes of Health Research
Variations in excitatory and inhibitory postsynaptic protein content in rat cerebral cortex with respect to aging and cognitive status
M Majdi, A Ribeiro-da-Silva, AC Cuello
Neuroscience 159 (2), 896-907, 2009
Mandates: US National Institutes of Health
Changes with aging in the dopaminergic and noradrenergic innervation of rat neocortex
S Allard, V Gosein, AC Cuello, A Ribeiro-da-Silva
Neurobiology of aging 32 (12), 2244-2253, 2011
Mandates: US National Institutes of Health, Canadian Institutes of Health Research
Searching for new pharmacological targets for the treatment of Alzheimer's disease in Down syndrome
F Caraci, MF Iulita, R Pentz, LF Aguilar, C Orciani, C Barone, C Romano, ...
European journal of pharmacology 817, 7-19, 2017
Mandates: Canadian Institutes of Health Research, Fonds de recherche du Québec - Santé
Effect of antioxidant supplements on lipid peroxidation levels in primary cortical neuron cultures
MK Foret, S Do Carmo, R Lincoln, LE Greene, W Zhang, AC Cuello, ...
Free Radical Biology and Medicine 130, 471-477, 2019
Mandates: Canadian Institutes of Health Research, Natural Sciences and Engineering …
Cortical peroxynitration of nerve growth factor in aged and cognitively impaired rats
MA Bruno, AC Cuello
Neurobiology of aging 33 (9), 1927-1937, 2012
Mandates: Canadian Institutes of Health Research
Early loss of locus coeruleus innervation promotes cognitive and neuropathological changes before amyloid plaque deposition in a transgenic rat model of Alzheimer's disease
L Flores‐Aguilar, H Hall, C Orciani, MK Foret, O Kovecses, ...
Neuropathology and Applied Neurobiology 48 (6), e12835, 2022
Mandates: Canadian Institutes of Health Research, Fonds de recherche du Québec - Santé …
Nonsteroidal anti-inflammatory drugs (NSAIDs) and derived Aβ42-lowering molecules for treatment and prevention of Alzheimer's disease (AD)
AC Cuello, S Weggen, E Czirr, S Leuchtenberger, J Eriksen
Pharmacological Mechanisms in Alzheimer's Therapeutics, 167-193, 2007
Mandates: German Research Foundation
Publication and funding information is determined automatically by a computer program